(-)-Gossypol reduces invasiveness in metastatic prostate cancer cells

Yi-Wen Huang1, Li-Shu Wang, Michael K Dowd

  • 1Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, The Ohio State University, Columbus, OH, U.S.A.

Anticancer Research
|June 17, 2009
PubMed
Abstract

Insights

(-)-Gossypol, a cottonseed compound, inhibits prostate cancer cell invasion. This study found it reduced the invasive ability of both standard (MAT-LyLu) and metastatic (MLL) rat prostate cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Prostate cancer metastasis is a lethal aspect of disease progression.
  • (-)-Gossypol, a natural compound, exhibits anti-cancer properties.
  • Understanding differences in metastatic potential is crucial for treatment.

Purpose of the Study:

  • To compare the metastatic potential of MAT-LyLu and a novel MLL rat prostate cancer cell subline.
  • To evaluate the effects of (-)-gossypol on the viability, invasion, and migration of these cell lines.

Main Methods:

  • Comparison of cell growth and invasion between MAT-LyLu and MLL cells.
  • Assessment of (-)-gossypol's impact on cell viability, colony formation, invasion, and migration.
  • Analysis of key protein expression (Bcl-xL, nm23-H1, Bcl-2) in response to (-)-gossypol.

Main Results:

  • MLL cells demonstrated significantly higher growth, colony formation, and invasion compared to MAT-LyLu cells.
  • MLL cells showed lower expression of Bcl-xL and nm23-H1 proteins than MAT-LyLu cells.
  • (-)-Gossypol dose-dependently inhibited cell viability and invasion, reduced Bcl-2/Bcl-xL, and increased nm23-H1 protein levels.

Conclusions:

  • (-)-Gossypol effectively reduces in vitro invasion in both prostate cancer cell lines.
  • These findings suggest (-)-gossypol's potential as a chemotherapeutic or chemopreventive agent for prostate cancer.